The Second Affiliated Hospital of Harbin Medical University — Harbin, Heilongjiang

Public research footprint of The Second Affiliated Hospital of Harbin Medical University, compiled from the ClinicalTrials.gov public registry.

107

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Plaque Psoriasis · Neovascular Age-Related Macular Degeneration (nAMD) · Atherosclerotic Renal Artery Stenosis · AF - Atrial Fibrillation

Recently updated registry entries

NCT07317934 — Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related… (Recruiting)
NCT05800873 — Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001 (Completed)
NCT05562947 — A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Second Affiliated Hospital of Harbin Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.